/ /


Sizing up daily disposable contact lensesMost ODs could list all the missing items in their contact lens supply line. They could construct a wish list of products they would like to see available in the future. On days when we find ourselves ransacking the contact lens trial room, ODs may think technology is moving too slowly. Perhaps it’s time for some needed perspective.
Researchers image single cell deaths in glaucoma patientsA new imaging technique can show the deaths of individual cells in people with glaucoma by labelling the cells with fluorescent dye, according to researchers. The approach might eventually be used to diagnosis the disease in its early stages or measure its progression.
Genetic testing initiative for inherited retinal diseases shows great promiseI have been encouraged as a retinal specialist with all the excitement and promising new treatments in gene therapy. Given that there are several retinal diseases with known inherited patterns and confirmed genetic loci responsible for the clinical manifestations, our field is primed to benefit from the expansion of knowledge in this arena.
Diagnosing CHRPE lesions can be a challenge for ODsA 26-year-old healthy ophthalmically asymptomatic female patient attended the University of Alabama School of Optometry clinic for a periodic ophthalmic evaluation. Her history was significant for myopic refractive correction, for which she wore soft contact lenses successfully.
Optimizing CPC treatment outcomes with built-in transilluminationA new probe offers combined transillumination and laser fiber for targeted transscleral cyclophotocoagulation. Steven D. Vold, MD, shares some of his clinical experience.
The Alcon DAILIES® Choice Program is a Win for Patients and PracticesFor many eye care professionals (ECPs), helping patients see, look and feel their best means being able to offer their patients daily disposable contact lenses. The DAILIES® Choice Program is an opportunity to provide patients with a convenient alternative to weekly and monthly replacement lenses by reducing the price barrier for new wearers with up to $200 in savings on a year’s supply of DAILIES® lenses.
Aflibercept rivals laser for diabetic retinopathyIntravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers.
Optimize patients’ CL experience by avoiding 3 bad habits
Optimize patients’ CL experience by avoiding 3 bad habitsJust as ODs develop good habits, there are bad habits that we should avoid. Avoid the following three habits to optimize your patients’ lens wearing experience.
New molecule enhances effect of anti-VEGF therapy for DMEActivation of Tie2–as a result of subcutaneous administration of AKB-9778 (Aerpio Therapeutics) in combination with an anti-vascular endothelial growth factor (anti-VEGF) therapy–enhances the effect of an anti-VEGF drug on diabetic macular edema (DME).
Insights from anti-VEGF pivotal DME trialsAnalyses of data collected in the RISE/RIDE and VIVID/VISTA clinical trials provide important messages about the efficacy and safety of ranibizumab (Lucentis, Genentech) and aflibercept (Eylea, Regeneron) for treatment of diabetic macular edema (DME).